Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 487.50 3.34
Hindalco 163.05 1.65
Bharti A 402.30 1.28
Tata Pow 92.60 1.93
Tcs Ltd 2581.00 0.90
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Piramal Enterprises Limited
Piramal Enterprises Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500302NSE:PELBloomberg:PIEL@INReuters:PIRA.BO
Market Lot: 1Face Value: 2ISIN Demat: INE140A01024
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
28-AUG-14 Piramal Enterprises, one of India's largest diversified companies with a presence in pharmaceutical, financial services, announced that the company and Navin Fluorine International, as Arvind Mafatlal Group Company have agreed to form a joint venture company to develope, manufacture and sell specialty fluorochemicals with specific focus on applications in healthcare. 30-JUL-14 Piramal Enterprises (PEL) and APG Asset Management, the D...   More..
Business Profile Future Plans
CEO Talk
Nicholas Piramal is confident that it will survive in the post-2005 era, when product patents become effective as it aims to partner multinational companies.   Vijay Shah
One To One
Recent news
Latest News
Piramal Enterprises turns to loss in Jul-Sep quarter  -IRIS 21-Oct-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Sep-2014(6)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 9658.9018134.7013803.70
Other Income1735.401868.601592.40
Total Income11394.3020003.3015396.10
Cost of goods sold9146.3017791.4015292.90
OPBDIT2248.002211.90103.20
PAT25383.50-3700.00-2315.60
Gross Block---
Equity capital345.10345.10345.10
EPS (Rs.)--21.40-13.40
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI)19.711.1 0.7
Net margin (% of OI)222.8-18.5-15.0
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Piramal Tower Annexe
Ganpatrao Kadam Marg
Lower Parel
Mumbai
Maharashtra-400 013
PHONE
(022) 3046 7953
FAX
(022) 2490 2363
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer